Contact information
gary.ford@rdm.ox.ac.uk
gary.ford@ouh.nhs.uk
Jo Harrison
Jo-Anne.Harrison@oxfordahsn.org
Colleges
Gary Ford
FRCP, FMedSci
Professor of Stroke Medicine
- Chief Executive Officer, Oxford Academic Health Science Network
- Consultant Stroke Physician OUH
My work focuses on developing and evaluating treatments that can reduce brain damage in the first few hours after stroke, and developing better processes of care to deliver for stroke patients.
I have developed and evaluated the performance of stroke recognition instruments such as the Face Arm Speech Test (FAST) and Recognition of Stroke in the Emergency Room Scale (ROSIER) to improve early diagnosis of stroke by the public, ambulance paramedics and Emergency Department teams.
My work has evaluated the risks and benefits of thrombolysis in very elderly stroke patients 80 years or older, who are the population at highest risk of stroke.
In addition to my research in stroke my work more broadly seeks to understand the risks and benefits of drug therapies in older people.
Recent publications
The impact of levodopa on post-stroke depression: the ESTREL-depression-study.
Journal article
Sauter MI. et al, (2026), Eur Stroke J, 11
Specialist PrE-hospital rEDirection for ischaemic stroke thrombectomY (SPEEDY): study protocol for a cluster randomised controlled trial with included health economic and process evaluations.
Journal article
Shaw L. et al, (2026), BMJ Open, 16
Stroke Action Plan for Europe 2018-2030 (SAP-E): mid-term review and update.
Journal article
Christensen H. et al, (2026), Eur Stroke J, 11
ificial intelligence imaging decision support for acute stroke treatment in England: a prospective observational study.
Journal article
Nagaratnam K. et al, (2025), Lancet Digit Health, 7
Levodopa Added to Stroke Rehabilitation: The ESTREL Randomized Clinical Trial.
Journal article
Engelter ST. et al, (2025), JAMA, 334, 1523 - 1532
ORCID
0000-0001-8719-4968
